sk&f 105809 has been researched along with galactosamine in 1 studies
| Studies (sk&f 105809) | Trials (sk&f 105809) | Recent Studies (post-2010) (sk&f 105809) | Studies (galactosamine) | Trials (galactosamine) | Recent Studies (post-2010) (galactosamine) |
|---|---|---|---|---|---|
| 8 | 0 | 0 | 3,542 | 7 | 704 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badger, AM; Esser, KM; Greig, RG; Lee, JC; Olivera, DL | 1 |
1 other study(ies) available for sk&f 105809 and galactosamine
| Article | Year |
|---|---|
Beneficial effects of SK&F 105809, a novel cytokine-suppressive agent, in murine models of endotoxin shock.
Topics: Animals; Cytokines; Disease Models, Animal; Galactosamine; Humans; Imidazoles; In Vitro Techniques; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Monocytes; Propionibacterium acnes; Shock, Septic; Tumor Necrosis Factor-alpha | 1992 |